Onkar N Singh

USPTO Granted Patents = 13 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 257(Granted Patents)

Company Filing History:

Alcon Pharmaceuticals Ltd.

patents

6. 1 out of 449

Alcon Laboratories, Inc.

patents

Years Active: 2001-2017

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9533053 - High concentration olopatadine ophthalmic composition (2017-01-03),

2. 8791154 - High concentration olopatadine ophthalmic composition (2014-07-29),

3. 8399508 - Olopatadine formulations for topical nasal administration (2013-03-19),

4. 8173671 - Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate (2012-05-08),

5. 7977376 - Olopatadine formulations for topical nasal administration (2011-07-12),

6. 7888370 - Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate (2011-02-15),

7. 7402609 - Olopatadine formulations for topical administration (2008-07-22),

8. 7001615 - Sustained release ophthalmic, otic and nasal suspension (2006-02-21),

9. 6995186 - Olopatadine formulations for topical administration (2006-02-07),

10. 6486208 - Sustained release, and comfortable opthalmic composition and method for ocular therapy (2002-11-26),

11. 6462033 - Process for manufacturing compositions containing ciprofloxacin and hydrocortisone (2002-10-08),

12. 6359016 - Topical suspension formulations containing ciprofloxacin and dexamethasone (2002-03-19),

13. 6284804 - Topical suspension formulations containing ciprofloxacin and dexamethasone (2001-09-04),

Title: Unveiling the Inventive Mind of Onkar N Singh

Introduction:

In the realm of innovation, Onkar N Singh stands as a beacon of creativity and problem-solving. Hailing from Arlington, TX, his inventive spirit has led to the development of numerous groundbreaking solutions in the field of ophthalmology.

Latest Patents:

Onkar N Singh's latest patents showcase his expertise in creating high concentration olopatadine ophthalmic compositions. These compositions feature a unique blend of ingredients aimed at providing enhanced relief from symptoms of ocular allergic conjunctivitis, with a focus on alleviating late phase symptoms. His dedication to improving eye care through innovative formulations is evident in these cutting-edge patents.

Career Highlights:

During his career, Onkar N Singh has made significant contributions to companies like Alcon Research, Ltd. and Alcon, Inc. His tenure at these renowned organizations has been marked by a commitment to excellence and a relentless pursuit of novel solutions in the field of ophthalmic research and development. His innovative approach has garnered recognition and respect within the industry.

Collaborations:

In his quest for innovation, Onkar N Singh has collaborated with esteemed colleagues such as Ernesto J Castillo and Haresh G Bhagat. Together, they have synergized their expertise and creativity to push the boundaries of ophthalmic technology and create impactful solutions that benefit patients worldwide. The spirit of collaboration and shared vision has been a driving force behind their collective success.

Conclusion:

In conclusion, Onkar N Singh's inventive prowess and dedication to advancing ophthalmic care have solidified his position as a visionary inventor. Through his latest patents and collaborative efforts, he continues to shape the landscape of innovation in the field, leaving a lasting impression on the industry. His contributions serve as a testament to the power of creativity and perseverance in transforming ideas into tangible solutions that make a difference in people's lives.

This text is generated by artificial intelligence and may not be accurate.